Related Attributes
Product details
Ozefloxacin acts by inhibiting bacterial DNA replicase, DNA cyclase A and topoisomerase IV. Ozefloxacin is the third non-fluoroquinolone antibiotic approved in the world after Nenofloxacin and Garefloxacin. In clinical trials, Ozefloxacin was used to treat skin and soft tissue infections, and the efficacy was superior to mupirocin, with no significant adverse effects. The inhibitory effect of ozefloxacin on MRSA, methicillin-sensitive Staphylococcus aureus (MSSA) and ofloxacin-resistant Staphylococcus aureus was significantly stronger than that of nafloxacin, ofloxacin, levofloxacin, chlorlincomycin, erythromycin and gentamicin. Ozefloxacin has strong bactericidal activity and can be used as a new quinolone with a short course of treatment and a good clinical application prospect.
Uses of Ozenoxacin.
For the treatment of impetigo caused by infection with Staphylococcus aureus or Streptococcus pyogenes in patients aged two months and older.
Preparation of Ozenoxacin.
Product method of Ozenoxacin.
Why choose us?
HRK Factory
About Shipping
Pharmaceutical Intermediate manufacturers
©2022 Xi'an Henrikang Biotech Co., Ltd.,